SCHEMBL4870429

SCHEMBL4870429

CC[C@@H]1C(=O)N(CC)c2ccc(F)cc2N1C(=O)c1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
HSD11B1 P28845 1/20 0.44
CBX7 O95931 1/20 0.43
CDYL2 Q8N8U2 1/20 0.43
CDYL Q9Y232 1/20 0.43
USP2 O75604 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.39
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864075 0.89 USP2 (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4867553 0.89 USP2 (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4863675 0.87 ALDH1A1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4864150 0.86 KMT2A (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4870059 0.85 USP2 (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4862053 0.83 USP2 (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2HSD11B1
SCHEMBL4490943 0.81 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL4867992 0.81 KMT2A (0.43) KMT2AMEN1USP2TSHR
SCHEMBL4866414 0.81 KMT2A (0.43) KMT2AMEN1USP2TSHR
SCHEMBL4867565 0.81 ALDH1A1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US disclosed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019961-A1 Estrogen receptor ligands GPER1, ESR2, ESR1 ALDH1A1 1051/4885NPC1 1178/4885RAB9A 3365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.